Analystreport

Ascendis Pharma A/S (NASDAQ: ASND) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $102.00 price target on the stock.

Ascendis Pharma A/S - American Depositary Shares  (ASND) 
Last ascendis pharma a/s - american depositary shares earnings: 11/18 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ascendispharma.com